nach oben

Clinical and Translational Oncology

Erschienen in:

01.08.2013 | Educational Series - Red Series

Radiosensitization by gold nanoparticles

verfasst von: B. Jeremic, A. R. Aguerri, N. Filipovic

Erschienen in: Clinical and Translational Oncology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Recent years brought increasing use of gold nano particles (GNP) as a model platform for interaction of irradiation and GNPs aiming radiosensitization. Endocytosis seems to be one of the major pathways for cellular uptake of GNPs. Internalization mechanism of GNPs is likely receptor-mediated endocytosis, influenced by GNP size, shape, its coating and surface charging. Many showed that DNA damage can occur as a consequence of metal-enhanced production of low energy electrons, Auger electrons and alike. Kilovoltage radiotherapy (RT) carries significantly higher dose enhancement factor (DEF) that is observed with megavoltage irradiations, the latter usually been at the order of 1.1–1.2. Higher gold concentrations seem to carry higher risk of toxicity, while with lower concentrations the DEF can be reduced. Adding a chemotherapeutic agent could increase level of enhancement. Clinical trials are eagerly awaited with a promise of gaining more knowledge deemed necessary for more successful transition to widespread clinical practice.

ASTM International, E-2456-06 (2006) Terminology for nanotechnology. ASTM International, West Conshohocken

Turkevich J, Hiller J, Stevenson PC (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 11:55–75CrossRef

Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759–1782PubMedCrossRef

Shukla R, Bansal V, Chaudhary M et al (2005) Biocompatibility mod gold nanoparticles and their endocytic fate inside the cellular compartment: a microscopic overview. Langmuir 21:10644–10654PubMedCrossRef

Hainfeld JF, Dilmanian FA, Slatkin DN et al (2008) Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 60:977–985PubMedCrossRef

Hainfeld JF, Slatkin DN, Smilowitz HM (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49:N309–N315PubMedCrossRef

Kong T, Zeng J, Wang X et al (2008) Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 4:1537–1543PubMedCrossRef

Rahman WN, Bishara N, Ackerly T et al (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomed Nanotechnol Biol Med 5:136–142CrossRef

Butterworth KT, Coulter JA, Jain S et al (2010) Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 21:295101

10.

Chithrani BD, Ghazani AA, Chen WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668PubMedCrossRef

11.

Chithrani BD, Stewart J, Allen C et al (2009) Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomedicine 5:118–127PubMedCrossRef

12.

Mukherjee S, Ghosh RN, Maxfield FR (1997) Endocytosis. Physiol Rev 77:759–803PubMed

13.

Jin H, Heller DA, Strano MS et al (2009) Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3:149–158PubMedCrossRef

14.

Xu X-HN, Brownlow WJ, Kyriacou SV et al (2004) Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging. Biochem 43:10400–10413CrossRef

15.

Arnida, Malugin A, Ghandehari H (2009) Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 30:212–217

16.

Cartiera MS, Johnson KM, Rajendran V et al (2009) The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 30:2790–2798PubMedCrossRef

17.

Aoyama Y, Kanamori T, Nakai T et al (2003) Artificial viruses and their application to gene delivery. Size-controlled gene coating with glycocluster nanoparticles. J Am Chem Soc 125:3455–3457PubMedCrossRef

18.

Nakai T, Kanemori T, Sando S et al (2003) Remarkably size-regulated cell invasions by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. J Am Chem Soc 125:8465–8475PubMedCrossRef

19.

Osaki F, Kanemori T, Sando S et al (2004) A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J Am Chem Soc 126:6520–6521PubMedCrossRef

20.

Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102:9469–9474PubMedCrossRef

21.

Shi W, Wang J, Fan X, Gao H (2008) Size and shape effects on diffusion and absorption of colloidal particles near a partially absorbing sphere: implications for uptake of nanoparticles in animal cells. Phy Rev E 78:061914–061925CrossRef

22.

Chithrani DB (2010) Intracellular uptake, transport, and processing of gold nanostructures. Mol Membr Biol 27:299–311PubMedCrossRef

23.

Cho EC, Xie J, Wurm PA et al (2009) Understanding the role of surface charge sin cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett 9:1080–1084PubMedCrossRef

24.

Vertegel AS, Siegel RW, Dordick JS (2004) Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 20:6800–6807PubMedCrossRef

25.

Aubin-Tam M-E, Hamad-Schifferli K (2005) Gold nanoparticle—cytochrome c complexes: the effect of nanoparticle ligand charge on protein structure. Langmuir 21:12080–12084PubMedCrossRef

26.

Yang Z, Leon J, Martin M et al (2009) Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 20:165101PubMedCrossRef

27.

Ishida O, Maruyama K, Sasaki K et al (1999) Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 190:49–56PubMedCrossRef

28.

Perrault SD, Walkey C, Jennings T et al (2009) Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9:1909–1915PubMedCrossRef

29.

Chen J, Irudayaraj J (2009) Quantitative investigation of compartmentalized dynamics of erbB2 targeting gold nanorods in live cells by single molecule spectroscopy. ACS Nano 3:4071–4079PubMedCrossRef

30.

Lukacs GL, Haggie P, Seksek O et al (2000) Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 275:1625–1629PubMedCrossRef

31.

Goldstein JL, Anderson RGW, Brown MS (1979) Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679–685PubMedCrossRef

32.

See L, Free P, Cesbron Y et al (2009) Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano 3:2461–2468PubMedCrossRef

33.

Taylor U, Klein S, Petersen S et al (2010) Nonendosomal cellular uptake of ligand-free, positively charged nanoparticles. Cytometry A 77A:439–446

34.

Panyam J, Zhou WZ, Prabhs S et al (2002) Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16:1217–1226PubMedCrossRef

35.

Chithrani BD, Chan WCW (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542–1550PubMedCrossRef

36.

Nativo P, Prior IA, Brust M (2008) Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2:1639–1644PubMedCrossRef

37.

Tkachenko AG, Xie H, Coleman D et al (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc 125:4700–4701PubMedCrossRef

38.

Tkachenko A, Xie H, Liu Y et al (2004) Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjugate Chem 15:482–490CrossRef

39.

Connor EE, Mwamuka J, Gole A et al (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327PubMedCrossRef

40.

Rayavarapu RJ, Petersen W, Ungureanu C et al (2007) Synthesis and bioconjugation of gold nanoparticles as potential probes for light-based imaging techniques. In J Biomed Imag 2007:1–10CrossRef

41.

Berry CC, de la Fuente JM, Mullin M et al (2007) Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nano Biosci 6:262–269CrossRef

42.

Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207PubMedCrossRef

43.

Maki S, Konno T, Maeda H (1985) Image enhancement in computerised tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56:751–757PubMedCrossRef

44.

Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Res 63:136–151CrossRef

45.

Kaul G, Amiji M (2002) Long-circulating poly(ethylene glycol)-modified gelating nanoparticles for intracellular delivery. Pharm Res 19:1061–1067PubMedCrossRef

46.

Cho SH (2005) Estimation of tumor dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol 50:N163–N173PubMedCrossRef

47.

Roeske JC, Nunez L, Hoggarth M et al (2007) Characterization of the theoretical dose enhancement from nanoparticles. Technol Cancer Res Treat 6:395–401PubMed

48.

McMahon SJ, Mendenhall MH, Jain S et al (2008) Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol 53:5635–5651PubMedCrossRef

49.

Cho SH, Jones BL, Krishnan S (2009) The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/X-ray sources. Phys Med Biol 54:4889–4905PubMedCrossRef

50.

Carter JD, Cheng NN, Qu Y et al (2007) Nanoscale energy deposition by X-ray absorbing nanostructures. J Phys Chem 111:11622–11625

51.

Boudaiffa B, Cloutier P, Hunting DJ et al (2000) Resonant formation of DNA strand breaks by low-energy (3–20 eV) electrons. [Report]. Science 287:1658–1660PubMedCrossRef

52.

Roa W, Zhang X, Guo L et al (2009) Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of cell cycle. Nanotechnology 20:375101PubMedCrossRef

53.

Chang M, Shiau A, Chen Y et al (2008) Increased apoptotic potential and dose-enhancing effects of gold nanoparticles in combination with single-dose clinical electron beams on tumor bearing mice. Cancer Sci 99:1479–1484PubMedCrossRef

54.

Chithrani DB, Jelveh S, Jalali F et al (2010) Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173:719–728PubMedCrossRef

55.

Liu C-J, Wang C-H, Chien C–C et al (2008) Enhanced X-irradiation-induced cancer cell damage by gold nanoparticles treated by anew synthesis method of polyethylene glycol modification. Nanotechnology 19:295104–295109PubMedCrossRef

56.

Hainfeld JF, Dilmanian FA, Zhong Z et al (2010) Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 55:3045–3059PubMedCrossRef

57.

Kirschenbaum J, Riesz P (2009) Enhancement of 5-aminolevulinic acid-induced oxidative stress on two cancer cell lines by gold nanoparticles. Free Radic Res 43:1214–1224PubMedCrossRef

58.

Kassis AI (2004) The amazing world of Auger electrons. Int J Radiat Biol 11–12:789–803CrossRef

59.

Sanche L (2005) Low-energy electron-driven damage in biomolecules. Eur Phys J D 35:367–390CrossRef

60.

Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist, 6th edn. Lippincott Williams & Wilkins, Philadelphia

61.

Leung MKK, Chow JCL, Chithrani BD et al (2011) Irradiation of gold nanoparticles by X-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electron production. Med Phys 38:624–631PubMedCrossRef

62.

Jain S, Coulter JA, Hounsell AR et al (2011) Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys 79:531–539PubMedCrossRef

63.

Patra HK, Banerjee S, Chaudhuri U et al (2007) Cell selective response to gold nanoparticles. Nanomedicine 3:111–119PubMedCrossRef

64.

Cho WS, Cho M, Jeong J et al (2009) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24PubMedCrossRef

65.

McMahon SJ, Hyland WB, Muir MF et al (2011) Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep 1:18PubMedCrossRef

66.

Lechtman E, Chattopadhyay N, Cai Z et al (2011) Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol 56:4631–4647PubMedCrossRef

67.

Brun E, Sanche L, Sicard-Roselli C (2009) Parameters governing gold nanoparticles X-ray sensitization of DNA in solution. Colloids Surf B 72:128–134CrossRef

68.

Rahman WN, Wong CJ, Ackerly T et al (2012) Polymer gels impregnated with gold nanoparticles implemented for measurements of radiation dose enhancement in synchrotron and conventional radiotherapy type beams. Australas Phys Eng Sci Med 35:301–309PubMedCrossRef

69.

Zhang C, Huang P, Bao L et al (2011) Enhancement of gastric cell radiation sensitivity by chitosan-modified gold nanoparticles. J Nanosci Nanotechnol 11:9528–9535PubMedCrossRef

70.

Berbeco RI, Ngwa W, Makrigiorgios GM (2011) Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys 81:270–276PubMedCrossRef

71.

Pan Y, Neuss S, Leifert A et al (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941–1949PubMedCrossRef

72.

Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4:26–49PubMedCrossRef

73.

Herold DM, Das IJ, Stobe CC et al (2000) Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 76:1357–1364PubMedCrossRef

74.

Hainfeld JF, Foley CF, Shrivastava SC et al (1990) Radioactive gold cluster immunoconjugates: potential agents for cancer therapy. Nucl Med Biol 17:287–294

75.

Niidome T, Nakashima H, Takahashi Y et al (2004) Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. Chem Commun 17:1978–1979CrossRef

76.

Dvorak HF, Nagy JA, Dvorak JT et al (1988) Identification and characterisation of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133:95–109PubMed

77.

Gratton SEA, Ropp PA, Polhaus PD et al (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci 105:11613–11618PubMedCrossRef

78.

Champion JA, Mitragotri S (2009) Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26:244–249PubMedCrossRef

79.

Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:662–667CrossRef

80.

Cho EC, Au L, Zhang Q et al (2009) The effects of size, shape, and surface functional group of gold nanoparticles on their adsorption and internalization by cells. Small 6:517–522CrossRef

81.

Sayes CM, Reed KL, Warheit DB (2007) Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163–180PubMedCrossRef

82.

Goodman CM, McCucker CD, Yilmaz T et al (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897–900PubMedCrossRef

83.

Pernodet N, Fang X, Sun Y et al (2006) Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2:766–773PubMedCrossRef

84.

Murphy CJ, Gole AM, Stone JW et al (2008) Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 41:1721–1730PubMedCrossRef

85.

Male KB, Lachance B, Hrapovic S et al (2008) Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy. Anal Chem 80:5487–5493PubMedCrossRef

86.

Zhang X-D, Wu HY, Wu D et al (2010) Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed 5:771–781CrossRef

87.

de Jong WH, Hagens WI, Krystek P et al (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–1919PubMedCrossRef

88.

Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66:274–280PubMedCrossRef

89.

Chen YS, Hung YC, Liau I et al (2009) Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 4:858–864PubMedCrossRef

90.

Cho WS, Kim S, Han BS et al (2009) Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 191:96–102PubMedCrossRef

91.

Semmler-Behnke M, Kreyling WG, Lipka J et al (2008) Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4:2108–2111PubMedCrossRef

92.

Lipka J, Semmler-Behnke M, Sperling RA et al (2010) Biodistribution of PED-modified gold nanoparticles following intrathecal instillation and intravenous injection. Biomaterials 31:6574–6581PubMedCrossRef

93.

Cho WS, Cho M, Jeong J et al (2010) Size-dependent tissue-kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245:116–123PubMedCrossRef

94.

Balasubramaniam SK, Jittiwat J, Manikandan J et al (2010) Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31:2034–2042CrossRef

95.

Balogh L, Nigavekar SS, Nair BM et al (2007) Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine 3:281–296PubMedCrossRef

96.

Zhang X-D, Wu D, Shen X et al (2012) Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33:6408–6419PubMedCrossRef

97.

Zhang X-D, Wu D, Shen X et al (2011) Size-dependent toxicity of PEG-coated gold nanoparticles. Int J Nanomed 6:2071–2081CrossRef

98.

Zhang X-D, Wu D, Shen X et al (2012) In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 33:4628–4638PubMedCrossRef

99.

Zheng Y, Hunting D, Ayotte P et al (2008) Role of secondary low energy electrons in the concomitant chemoradiation therapy of cancer. Phys Rev Lett 100:198101–198104PubMedCrossRef

100.

Pimblott SM, LaVerne JA (2007) Production of low energy electrons by ionizing irradiation. Radiat Phys Chem 76:1244–1249CrossRef

101.

Zheng L, Sanche L (2009) Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and irradiation. Radiat Res 172:114–119PubMedCrossRef

Titel: Radiosensitization by gold nanoparticles
verfasst von: B. Jeremic
A. R. Aguerri
N. Filipovic
Publikationsdatum: 01.08.2013
Verlag: Springer Milan
Erschienen in: Clinical and Translational Oncology / Ausgabe 8/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-013-1003-7

Springer Medizin

Radiosensitization by gold nanoparticles

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2013

A study of circulating anti-CD25 antibodies in non-small cell lung cancer

Planning target volume assessment in lung tumors during 3D conformal radiotherapy by means of an aSi electronic portal imaging device in cine mode

Do comorbidity influences acute toxicity and outcome in elderly patients with endometrial cancer treated by adjuvant radiotherapy plus brachytherapy?

The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas

Molecular biomarkers in the decision of treatment of cervical carcinoma patients

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie